Wellbiotec Co. Ltd. (010600) — Capital Reinvestment Ratio

Latest as of September 2024: 0.00x

Wellbiotec Co. Ltd. (010600) has a Capital Reinvestment Ratio of 0.00x as of September 2024, meaning it reinvests 0% of its operating cash flow (₩2.72 Billion) in capital expenditures (₩10.89 Million). Check how tangible is Wellbiotec Co. Ltd.'s equity to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

₩2.72 Billion
KRW

Capital Expenditures

₩10.89 Million
KRW

Data as of

Sep 2024
Most recent filing

Wellbiotec Co. Ltd. Capital Reinvestment Ratio (2005–2022)

This chart tracks Wellbiotec Co. Ltd.'s Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see 010600 cash flow metrics.

Annual Capital Reinvestment Ratio for Wellbiotec Co. Ltd. (2005–2022)

Year-by-year Capital Reinvestment Ratio for Wellbiotec Co. Ltd. from 2005 to 2022. See Wellbiotec Co. Ltd. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2022 0.19x ₩2.62 Billion ₩508.76 Million ▼ -75.6%
2021 0.79x ₩712.97 Million ₩565.92 Million ▲ +259.3%
2015 0.22x ₩4.28 Billion ₩944.92 Million ▼ -20.8%
2013 0.28x ₩1.01 Billion ₩281.62 Million ▲ +3.1%
2012 0.27x ₩3.06 Billion ₩826.93 Million ▲ +80.2%
2010 0.15x ₩2.90 Billion ₩435.67 Million ▼ -94.0%
2008 2.51x ₩3.11 Billion ₩7.82 Billion ▲ +212.3%
2006 0.81x ₩4.49 Billion ₩3.62 Billion ▼ -79.2%
2005 3.87x ₩1.48 Billion ₩5.72 Billion
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow